ABUS vs CAT
Arbutus Biopharma Corp (ABUS) versus Caterpillar Inc (CAT) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Not investment advice. Open the ABUS and CAT stock pages for the full models.
Not investment advice.